Want to join the conversation?
Pharmacy benefit manager $ESRX reported a 33% jump in 4Q15 earnings driven by lower costs and expenses despite a decline in revenue. Net income rose to $773.5MM or $1.13 per share from $581.8MM or $0.79 per share last year. Revenue slid to $26.18Bil from $26.31Bil. Adjusted EPS increased by 12% to $1.56.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.